Psychedelics

Is ATAI Life Sciences Stock a Buy Right Now?

ATAI Life Sciences NV'is down by 17% year-to-date. Should you buy the dip?

IPO Outlook: LSDI, QSG

The IPOs in focus for the week ahead include psychotropic ingredient outfit Lucy Scientific Discovery and online education specialists QuantaSing Group.

FTHW, NA, SNOW, RSI, PATH: Earnings Preview

This week’s company earnings include Field Trip Health & Wellness (FTHW), National Bank of Canada (NA) Snowflake (SNOW), Rogers Sugar (RSI), and UiPath (PATH).